Insights into the Mechanisms of Non-coding RNAs' Implication in the Pathogenesis of Alzheimer's Disease

Overview

Journal EXCLI J

Specialty Biology

Date 2022 Sep 16

PMID 36110561

Authors

Majid Khodayi-Shahrak

Mohammad Khalaj-Kondori

Mohammad Ali Hosseinpour Feizi

Mahnaz Talebi

Affiliations

Soon will be listed here.

Abstract

Non-coding RNAs including long non-coding RNAs (lncRNAs) and microRNAs (miRNAs) are implicated in the regulation of gene expression at transcriptional, posttranscriptional, and epigenetic levels. Several studies in cell lines, animal models, and humans, have revealed that non-coding RNAs play crucial roles in the pathogenesis of Alzheimer's disease (AD). Detailed knowledge on their mechanism of implication in the AD pathogenesis can help to develop novel therapeutic and disease management strategies. The two main pathological hallmarks of AD are amyloid plaques resulting from the β-amyloid accumulation, and neurofibrillary tangles (NFT) due to the phosphorylated tau accumulation. Several lncRNAs and miRNAs play crucial roles in both these hallmarks of the AD pathogenesis and other AD-related pathological procedures such as neuronal and synaptic plasticity, neuroinflammation, neuronal differentiation and neuronal apoptosis. In this review, we outlined the non-coding RNAs and further discussed how they are implicated in these AD-related pathological procedures.

Citing Articles

The siRNA-mediated knockdown of SNHG4 efficiently induced pro-apoptotic signaling and suppressed metastasis in SW1116 colorectal cancer cell line.

Khajehdehi M, Khalaj-Kondori M, Baradaran B Mol Biol Rep. 2023; 50(11):8995-9006.

PMID: 37715875 DOI: 10.1007/s11033-023-08742-5.

MicroRNA (miRNA) Complexity in Alzheimer's Disease (AD).

Lukiw W Biology (Basel). 2023; 12(6).

PMID: 37372073 PMC: 10295300. DOI: 10.3390/biology12060788.

References

Asadi M, Hassani M, Kiani S, Sabaie H, Moslehian M, Kazemi M . The Perspective of Dysregulated LncRNAs in Alzheimer's Disease: A Systematic Scoping Review. Front Aging Neurosci. 2021; 13:709568. PMC: 8490871. DOI: 10.3389/fnagi.2021.709568. View

Derrien T, Johnson R, Bussotti G, Tanzer A, Djebali S, Tilgner H . The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res. 2012; 22(9):1775-89. PMC: 3431493. DOI: 10.1101/gr.132159.111. View

Kou X, Chen D, Chen N . The Regulation of microRNAs in Alzheimer's Disease. Front Neurol. 2020; 11:288. PMC: 7180504. DOI: 10.3389/fneur.2020.00288. View

Huang Z, Zhao J, Wang W, Zhou J, Zhang J . Depletion of LncRNA NEAT1 Rescues Mitochondrial Dysfunction Through NEDD4L-Dependent PINK1 Degradation in Animal Models of Alzheimer's Disease. Front Cell Neurosci. 2020; 14:28. PMC: 7043103. DOI: 10.3389/fncel.2020.00028. View

Idda M, Munk R, Abdelmohsen K, Gorospe M . Noncoding RNAs in Alzheimer's disease. Wiley Interdiscip Rev RNA. 2018; 9(2). PMC: 5847280. DOI: 10.1002/wrna.1463. View

Arisi I, DOnofrio M, Brandi R, Felsani A, Capsoni S, Drovandi G . Gene expression biomarkers in the brain of a mouse model for Alzheimer's disease: mining of microarray data by logic classification and feature selection. J Alzheimers Dis. 2011; 24(4):721-38. DOI: 10.3233/JAD-2011-101881. View

Jandura A, Krause H . The New RNA World: Growing Evidence for Long Noncoding RNA Functionality. Trends Genet. 2017; 33(10):665-676. DOI: 10.1016/j.tig.2017.08.002. View

Patel N, Hoang D, Miller N, Ansaloni S, Huang Q, Rogers J . MicroRNAs can regulate human APP levels. Mol Neurodegener. 2008; 3:10. PMC: 2529281. DOI: 10.1186/1750-1326-3-10. View

Goodall E, Heath P, Bandmann O, Kirby J, Shaw P . Neuronal dark matter: the emerging role of microRNAs in neurodegeneration. Front Cell Neurosci. 2013; 7:178. PMC: 3794211. DOI: 10.3389/fncel.2013.00178. View

10.

Reitz C . The role of intracellular trafficking and the VPS10d receptors in Alzheimer's disease. Future Neurol. 2012; 7(4):423-431. PMC: 3524993. DOI: 10.2217/fnl.12.31. View

11.

Du W, Lei C, Dong Y . MicroRNA-149 is downregulated in Alzheimer's disease and inhibits β-amyloid accumulation and ameliorates neuronal viability through targeting BACE1. Genet Mol Biol. 2021; 44(1):e20200064. PMC: 7802068. DOI: 10.1590/1678-4685-GMB-2020-0064. View

12.

Scherzer C, Offe K, Gearing M, Rees H, Fang G, Heilman C . Loss of apolipoprotein E receptor LR11 in Alzheimer disease. Arch Neurol. 2004; 61(8):1200-5. DOI: 10.1001/archneur.61.8.1200. View

13.

Kazemzadeh M, Safaralizadeh R, Orang A . LncRNAs: emerging players in gene regulation and disease pathogenesis. J Genet. 2015; 94(4):771-84. DOI: 10.1007/s12041-015-0561-6. View

14.

Chen L, Guo X, Li Z, He Y . Relationship between long non-coding RNAs and Alzheimer's disease: a systematic review. Pathol Res Pract. 2018; 215(1):12-20. DOI: 10.1016/j.prp.2018.11.012. View

15.

Mus E, Hof P, Tiedge H . Dendritic BC200 RNA in aging and in Alzheimer's disease. Proc Natl Acad Sci U S A. 2007; 104(25):10679-84. PMC: 1965572. DOI: 10.1073/pnas.0701532104. View

16.

Mangialasche F, Solomon A, Winblad B, Mecocci P, Kivipelto M . Alzheimer's disease: clinical trials and drug development. Lancet Neurol. 2010; 9(7):702-16. DOI: 10.1016/S1474-4422(10)70119-8. View

17.

Holsinger R, Schnarr J, Henry P, Castelo V, Fahnestock M . Quantitation of BDNF mRNA in human parietal cortex by competitive reverse transcription-polymerase chain reaction: decreased levels in Alzheimer's disease. Brain Res Mol Brain Res. 2000; 76(2):347-54. DOI: 10.1016/s0169-328x(00)00023-1. View

18.

Huang W, Meng F, Cao J, Liu X, Zhang J, Li M . Neuroprotective Role of Exogenous Brain-Derived Neurotrophic Factor in Hypoxia-Hypoglycemia-Induced Hippocampal Neuron Injury via Regulating Trkb/MiR134 Signaling. J Mol Neurosci. 2017; 62(1):35-42. DOI: 10.1007/s12031-017-0907-z. View

19.

Roberts T, Morris K, Wood M . The role of long non-coding RNAs in neurodevelopment, brain function and neurological disease. Philos Trans R Soc Lond B Biol Sci. 2014; 369(1652). PMC: 4142028. DOI: 10.1098/rstb.2013.0507. View

20.

Faghihi M, Modarresi F, Khalil A, Wood D, Sahagan B, Morgan T . Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase. Nat Med. 2008; 14(7):723-30. PMC: 2826895. DOI: 10.1038/nm1784. View